Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). (Q48048391)
Jump to navigation
Jump to search
scientific article published in June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). |
scientific article published in June 2015 |
Statements
1 reference
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). (English)
1 reference
Jacek Jassem
1 reference
Jaffer A Ajani
1 reference
György Bodoky
1 reference
Max E Scheulen
1 reference
Fernando Rivera
1 reference
Alfredo Carrato
1 reference
Jana Prausová
1 reference
Jean-Luc Van Laethem
1 reference
1 June 2015
1 reference
46
1 reference
2
1 reference
109-117
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference